Drug intelligence / Profile preview

high-calorie mixed electrolyte infusion II

Development stage: Preclinical
Lead developer: Jilin Connell Pharmaceutical
Administration: Intravenous

Overview

High-Calorie Mixed Electrolyte Infusion II is a preclinical-stage intravenous infusion solution developed by Jilin Connell Pharmaceutical. It is designed to provide caloric support and replenish essential electrolytes in patients requiring parenteral nutrition. The formulation typically combines carbohydrates with a balanced mix of electrolytes to maintain homeostasis and prevent nutritional deficiencies in clinical settings where oral intake is insufficient or contraindicated. The product is part of the company's R&D pipeline for parenteral nutrition and fluid therapy.

Other names: High-Calorie Mixed Electrolyte Infusion No. II高热值混合电解质输液II号

Beyond the preview

Go deeper on high-calorie mixed electrolyte infusion II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on high-calorie mixed electrolyte infusion II.

Explore the full profile